Advertisement

Picture EBD Group BIO-Europe Spring 2025 Milan to 28 Feb 650x100px
Organisation › Details

Taiho Ventures LLC

Taiho Ventures, LLC is the corporate venture arm of Taiho Pharmaceutical Co., Ltd., a Japanese specialty pharmaceutical company focusing on oncology, allergy and immunology, and urology. With $300M under management, Taiho Ventures is actively investing in early-stage private companies strategically relevant to Taiho Pharmaceutical. The firm considers company creation, spinouts and the option-type of investments as well as pure equity investments. *

 

Period Start 2016-04-15 established
  Group Otsuka (Group)
Products Industry venture capital
  Industry 2 BIOTECH
Person Person Asanuma, Sakae (Otsuka 201705 President of Taiho Ventures)
     
Region Region Menlo Park, CA
  Country United States (USA)
  Street 2420 Sand Hill Road
Suite 203
  City 94025-6940 Menlo Park, CA
    Address record changed: 2020-12-02
     
Basic data Employees n. a.
  Currency USD
  Annual sales 300,000,000 (capital under management (2021) 2021-04-22)
     
    * Document for »About Section«: Anavo Therapeutics B.V.. (4/22/21). "Press Release: Anavo Therapeutics Launches with EUR 20 Million Seed Financing to Create Industry-Leading Pipeline of Allosteric Phosphatase Modulators". Leiden.
     
   
Record changed: 2025-01-19

Advertisement

Picture Berlin Partner Top News Aignostics Mayo Clinic Pathology 650x200px

More documents for Otsuka (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Swiss Biotech Association LSE Swiss Biotech Days 2025 Basel 650x300px




» top